These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 15945060)
1. Enhanced dopamine uptake in the striatum following repeated restraint stress. Copeland BJ; Neff NH; Hadjiconstantinou M Synapse; 2005 Sep; 57(3):167-74. PubMed ID: 15945060 [TBL] [Abstract][Full Text] [Related]
2. Acquisition of an appetitive behavior prevents development of stress-induced neurochemical modifications in rat nucleus accumbens. Nanni G; Scheggi S; Leggio B; Grappi S; Masi F; Rauggi R; De Montis MG J Neurosci Res; 2003 Aug; 73(4):573-80. PubMed ID: 12898542 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534 [TBL] [Abstract][Full Text] [Related]
4. Selective alterations of gene expression in mice induced by MPTP. Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605 [TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol. D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736 [TBL] [Abstract][Full Text] [Related]
6. Repeated exposure to social stress has long-term effects on indirect markers of dopaminergic activity in brain regions associated with motivated behavior. Lucas LR; Celen Z; Tamashiro KL; Blanchard RJ; Blanchard DC; Markham C; Sakai RR; McEwen BS Neuroscience; 2004; 124(2):449-57. PubMed ID: 14980394 [TBL] [Abstract][Full Text] [Related]
7. Dopaminergic innervation of the human striatum in Parkinson's disease. Porritt M; Stanic D; Finkelstein D; Batchelor P; Lockhart S; Hughes A; Kalnins R; Howells D Mov Disord; 2005 Jul; 20(7):810-8. PubMed ID: 15726582 [TBL] [Abstract][Full Text] [Related]
8. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. Bock N; Moll GH; Wicker M; Pilz J; RĂ¼ther E; Banaschewski T; Huether G; Rothenberger A Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972 [TBL] [Abstract][Full Text] [Related]
9. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism. Volz TJ; Schenk JO Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864 [TBL] [Abstract][Full Text] [Related]
10. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity. Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634 [TBL] [Abstract][Full Text] [Related]
11. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens. Mateo Y; Budygin EA; John CE; Banks ML; Jones SR J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348 [TBL] [Abstract][Full Text] [Related]
12. Enhanced dopamine transporter function in striatum during nicotine withdrawal. Hadjiconstantinou M; Duchemin AM; Zhang H; Neff NH Synapse; 2011 Feb; 65(2):91-8. PubMed ID: 20506223 [TBL] [Abstract][Full Text] [Related]
13. D2 autoreceptors are not involved in the down-regulation of the striatal dopamine transporter caused by alpha-methyl-p-tyrosine. Han S; Rowell PP; Carr LA Res Commun Mol Pathol Pharmacol; 1999; 104(3):331-8. PubMed ID: 10741383 [TBL] [Abstract][Full Text] [Related]
14. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490 [TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. Dickinson SD; Sabeti J; Larson GA; Giardina K; Rubinstein M; Kelly MA; Grandy DK; Low MJ; Gerhardt GA; Zahniser NR J Neurochem; 1999 Jan; 72(1):148-56. PubMed ID: 9886065 [TBL] [Abstract][Full Text] [Related]
17. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005 [TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628 [TBL] [Abstract][Full Text] [Related]
19. The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter. Lee ES; Chen H; Shepherd KR; Lamango NS; Soliman KF; Charlton CG Neurosci Res; 2004 Mar; 48(3):335-44. PubMed ID: 15154679 [TBL] [Abstract][Full Text] [Related]
20. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex. Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]